Trial Profile
Retrospective analysis of trabectedin plus pegylated liposomal doxorubicin in patients with recurrent ovarian cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Doxorubicin liposomal
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2016 New trial record